AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (230.5 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Editorial | Open Access

Precision immunotherapy for breast cancer: from biomarkers to clinical practice

Jie Mei1,2,*Kai Yang1,2,*Xinkang Zhang1,2Xiang Huang1 ( )Yongmei Yin1,3,4 ( )
Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China
The First Clinical Medicine College, Nanjing Medical University, Nanjing 211166, China
Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing Medical University, Nanjing 211166, China
Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 211166, China

*These authors contributed equally to this work.

Show Author Information

References

【1】
【1】
 
 
Cancer Biology & Medicine
Pages 320-326

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Mei J, Yang K, Zhang X, et al. Precision immunotherapy for breast cancer: from biomarkers to clinical practice. Cancer Biology & Medicine, 2026, 23(3): 320-326. https://doi.org/10.20892/j.issn.2095-3941.2025.0815

90

Views

2

Downloads

0

Crossref

0

Web of Science

0

Scopus

Received: 19 December 2025
Accepted: 05 February 2026
Published: 01 March 2026
©2026 The Authors.

Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0)